
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Emerging Markets from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/emerging-markets/topic/11413/</link>
        <description>Articles tagged with Emerging Markets from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>After rough &apos;12, PHCG looks to inject more life into business</title>
          <description>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</description>
          <link>http://www.mmm-online.com/after-rough-12-phcg-looks-to-inject-more-life-into-business/article/290582/</link>
          <pubDate>Thu, 25 Apr 2013 18:50:41 GMT</pubDate>
          <itunes:summary>An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Roche, Vital Art and Science, Gilead, Sanofi</title>
          <description>Roche and Isis pair up for Huntingtons, Vital&apos;s prescription vision app gets approved, FDA approval revives maligned morning sickness drug, Gilead sends hep C therapy to regulators and Sanofi&apos;s emerging market exposure grabs attention.</description>
          <link>http://www.mmm-online.com/business-briefs-roche-vital-art-and-science-gilead-sanofi/article/288107/</link>
          <pubDate>Tue, 09 Apr 2013 17:08:25 GMT</pubDate>
          <itunes:summary>Roche and Isis pair up for Huntingtons, Vital&apos;s prescription vision app gets approved, FDA approval revives maligned morning sickness drug, Gilead sends hep C therapy to regulators and Sanofi&apos;s emerging market exposure grabs attention.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Success in emerging markets hinges on broad network</title>
          <description>Execs told Booz &amp; Co researchers that the relationships web in emerging markets needs to be deeper than one-on-one sales pitches.</description>
          <link>http://www.mmm-online.com/success-in-emerging-markets-hinges-on-broad-network/article/287295/</link>
          <pubDate>Wed, 03 Apr 2013 14:50:50 GMT</pubDate>
          <itunes:summary>Execs told Booz &amp; Co researchers that the relationships web in emerging markets needs to be deeper than one-on-one sales pitches.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pharma&apos;s iPad, emerging-markets strategies to get 2nd look in 2013, agency execs predict</title>
          <description>From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.</description>
          <link>http://www.mmm-online.com/pharmas-ipad-emerging-markets-strategies-to-get-2nd-look-in-2013-agency-execs-predict/article/274051/</link>
          <pubDate>Thu, 27 Dec 2012 14:19:40 GMT</pubDate>
          <itunes:summary>From tech shifts to talent, and from emerging markets to engaging with social media, agency execs offer their predictions for what the New Year will bring.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Capgemini, HealthPrize and Warc International</title>
          <description>The amount of revenue pharma leaves on the table due to non-adherence is much more than previously thought, a new study suggests.</description>
          <link>http://www.mmm-online.com/company-news-capgemini-healthprize-and-warc-international/article/269823/</link>
          <pubDate>Mon, 26 Nov 2012 20:24:21 GMT</pubDate>
          <itunes:summary>The amount of revenue pharma leaves on the table due to non-adherence is much more than previously thought, a new study suggests.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Consumers to disease: You&apos;re not the boss of me</title>
          <description>A global study of consumer attitudes towards health found evidence for the &quot;empowered consumer&quot; hypothesis, with respondents expressing a greater sense of control over and responsibility for their health.</description>
          <link>http://www.mmm-online.com/consumers-to-disease-youre-not-the-boss-of-me/article/229790/</link>
          <pubDate>Tue, 28 Feb 2012 21:30:07 GMT</pubDate>
          <itunes:summary>A global study of consumer attitudes towards health found evidence for the &quot;empowered consumer&quot; hypothesis, with respondents expressing a greater sense of control over and responsibility for their health.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Merck, GSK expand sales forces in China</title>
          <description>Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.</description>
          <link>http://www.mmm-online.com/merck-gsk-expand-sales-forces-in-china/article/194211/</link>
          <pubDate>Thu, 13 Jan 2011 17:33:43 GMT</pubDate>
          <itunes:summary>Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  